ArTS Archivio della ricerca di Trieste

DAPAS, BARBARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.288
EU - Europa 6.531
AS - Asia 5.316
SA - Sud America 542
AF - Africa 161
OC - Oceania 48
Continente sconosciuto - Info sul continente non disponibili 13
AN - Antartide 1
Totale 23.900
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.076
SG - Singapore 1.829
CN - Cina 1.454
IT - Italia 1.243
PL - Polonia 1.128
SE - Svezia 822
DE - Germania 703
UA - Ucraina 510
VN - Vietnam 505
HK - Hong Kong 485
FR - Francia 428
BR - Brasile 406
GB - Regno Unito 362
KR - Corea 337
RU - Federazione Russa 333
FI - Finlandia 280
TR - Turchia 218
NL - Olanda 168
IE - Irlanda 134
IN - India 132
BG - Bulgaria 124
CA - Canada 121
MX - Messico 59
MA - Marocco 57
BE - Belgio 56
JP - Giappone 47
AU - Australia 45
AR - Argentina 41
BD - Bangladesh 41
CH - Svizzera 41
ES - Italia 35
AT - Austria 30
IQ - Iraq 29
ZA - Sudafrica 29
SA - Arabia Saudita 25
PK - Pakistan 22
CZ - Repubblica Ceca 19
SN - Senegal 19
TW - Taiwan 19
IR - Iran 18
EC - Ecuador 17
ID - Indonesia 16
RO - Romania 16
TH - Thailandia 16
VE - Venezuela 16
CL - Cile 15
EG - Egitto 15
PH - Filippine 15
CO - Colombia 13
UZ - Uzbekistan 12
JO - Giordania 11
LU - Lussemburgo 11
DZ - Algeria 10
EU - Europa 10
GR - Grecia 10
IL - Israele 10
KE - Kenya 10
LT - Lituania 10
MY - Malesia 10
RS - Serbia 10
AZ - Azerbaigian 9
PE - Perù 9
UY - Uruguay 9
AE - Emirati Arabi Uniti 8
KZ - Kazakistan 8
PY - Paraguay 8
DK - Danimarca 7
HR - Croazia 7
HU - Ungheria 7
NO - Norvegia 6
NP - Nepal 6
PT - Portogallo 6
SI - Slovenia 6
BO - Bolivia 5
EE - Estonia 5
MO - Macao, regione amministrativa speciale della Cina 5
TT - Trinidad e Tobago 5
BH - Bahrain 4
GD - Grenada 4
JM - Giamaica 4
MU - Mauritius 4
PA - Panama 4
AO - Angola 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
GE - Georgia 3
HN - Honduras 3
KG - Kirghizistan 3
LV - Lettonia 3
MN - Mongolia 3
OM - Oman 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
AL - Albania 2
CR - Costa Rica 2
ET - Etiopia 2
GT - Guatemala 2
GY - Guiana 2
KH - Cambogia 2
Totale 23.867
Salva come PNG Salva come JPEG
Città #
Ashburn 1.120
Ann Arbor 1.064
Singapore 1.064
Warsaw 1.012
Woodbridge 969
Fairfield 834
Chandler 823
Houston 708
San Jose 556
Jacksonville 471
Hong Kong 459
Trieste 439
Wilmington 397
Hefei 384
Beijing 336
Seattle 321
Seoul 321
Cambridge 294
Princeton 227
Boardman 221
Izmir 177
Los Angeles 165
Chicago 154
Ho Chi Minh City 144
Santa Clara 140
Dearborn 139
Columbus 129
Dublin 129
The Dalles 126
Sofia 122
Hanoi 121
Lauterbourg 121
Moscow 116
Dallas 103
Zgierz 98
Helsinki 95
Munich 83
London 82
Council Bluffs 78
Düsseldorf 75
Milan 70
Frankfurt am Main 69
Buffalo 68
New York 63
São Paulo 49
Brussels 48
Casablanca 47
San Diego 47
Redmond 40
North Bergen 39
Orem 39
Atlanta 37
Montreal 37
Turku 33
Tokyo 31
Duino-Aurisina 30
Phoenix 30
Washington 30
Bern 29
Kunming 29
Padova 29
Redwood City 29
Guangzhou 28
Shanghai 28
Ottawa 26
Bremen 25
Sydney 25
Chennai 24
Da Nang 23
Jinan 23
Denver 22
Toronto 22
Poplar 21
Grafing 20
San Francisco 20
Venezia 20
Dakar 19
Haiphong 19
Nanjing 19
Des Moines 18
Rome 17
Verona 17
Dong Ket 16
Johannesburg 16
Manchester 16
Mestre 16
Norwalk 16
Amsterdam 14
Brooklyn 14
Campinas 14
Hebei 14
Nuremberg 14
Paris 14
Roubaix 14
Boston 13
City of London 13
Falls Church 13
Fremont 13
Portsmouth 13
Redondo Beach 13
Totale 16.032
Salva come PNG Salva come JPEG
Nome #
Polysaccharides for the delivery of antitumor drugs 473
Polymer-mediated delivery of siRNAs to hepatocellular carcinoma: Variables affecting specificity and effectiveness 473
Potential applications of nanocellulose-containing materials in the biomedical field 456
Effect of cystic fibrosis sputum rheology on lungs drug delivery by inhalation 417
GT75 aptamer against eukaryotic elongation factor 1A as potential anticancer drug for castrate-resistant prostate cancer (CRPC). 393
Therapeutic potential of small interfering RNAs/micro interfering RNA in hepatocellular carcinoma 350
Strategies for delivery of siRNAs to ovarian cancer cells 330
Therapeutic potential of Nucleic acid-based drugs in coronary hyper-proliferative vascular diseases 314
Therapeutic potential and delivery strategies for nucleic acid-based drugs 300
The role of the transcription factor E2F1 in hepatocellular carcinoma 294
Strategies to optimize siRNA delivery to hepatocellular carcinoma cells 284
Novel Lipid and Polymeric Materials as Delivery Systems for Nucleic Acid Based Drugs 282
Serum Response Factor depletion affects the proliferation of the hepatocellular carcinoma cells HepG2 and JHH6 281
Recent advances in smart biotechnology: Hydrogels and nanocarriers for tailored bioactive molecules depot 280
Current strategies to improve the efficacy and the delivery of nucleic acid based drugs 267
Mathematical modeling of drug release from natural polysaccharides based matrices 266
Aptameric GT oligomers need to be complexed to ethoxylated polyethylenimine as pre-paired duplexes to efficiently exert their cytotoxic activity in human lymphoblastic cancer cells 263
A novel approach based on low-field NMR for the detection of the pathological components of sputum in cystic fibrosis patients 263
Membranes in Drug Delivery 256
Dissecting the role of the elongation factor 1A isoforms in hepatocellular carcinoma cells by liposome-mediated delivery of siRNAs 256
Characterization of nucleic acid molecule/liposome complexes and rheological effects on pluronic/alginate matrices 254
Bortezomib arrests the proliferation of hepatocellular carcinoma cells HepG2 and JHH6 by differentially affecting E2F1, p21 and p27 levels. 253
Aptamer targeting of the elongation factor 1A impairs hepatocarcinoma cells viability and potentiates bortezomib and idarubicin effects 251
Can low field nuclear magnetic resonance be used to monitor lung functionality of cystic fibrosis patients? 250
"Human cancer cell lines growth inhibition by GTn oligodeoxyribonucleotides recognizing single stranded DNA-binding proteins" 248
Alcohol reduces MMP-2 in humans and isolated smooth muscle cells. 244
Diagnostic and prognostic role of eEF1A in chronic lymphocytic leukaemia 244
Drug delivery from polymeric matrices 243
A rapid and specific method to simultaneously quantify eukaryoticelongation factor 1A1 and A2 protein levels in cancer cells 239
Impairment of the Pin1/E2F1 axis in the anti-proliferative effect of bortezomib in hepatocellular carcinoma cells 235
Effects of E2F1-cyclinE1-E2 circuit down-regulation in hepatocellular carcinoma cells 233
Translation Elongation 233
Can rheology be useful in the cystic fibrosis frame 231
Aptamers as nano-targeting delivery devices or anti-cancer drugs for fighting tumours 229
Dissecting the expression of EEF1A1/A2 genes in human prostate cancer cells: the potential od EEF1A2 as a hallmark for prostate transformation and progression 227
Combined use of rheology and portable low-field NMR in cystic fibrosis patients 219
Characterisation of nucleid acid molecule/liposome complexes and rheological effects on pluronic/alginate matrices 211
A siRNA targeted against SRF reduce hepatocellular carcinoma cell proliferation, showing its potential use in the growth inhibition of this type of tumor 211
"Charactherization of nucleic acid molecule/liposome complexes and rheological effects on pluronic/alginate matrices" 209
Effects of hypoxia and bed rest on markers of cardiometabolic risk: Compensatory changes in circulating trail and glutathione redox capacity 207
A siRNA targeted against SRF reduce hepatocellular carcinoma cell proliferation, showing its potential use in the growth inhibition of this type of tumor 204
Effects of eEF1A1 targeting by aptamer/siRNA in chronic lymphocytic leukaemia cells 204
Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials 202
PDPG Polymer as a targeted delivery system for siRNAs to hepatocellular carcinoma cells 202
The expression levels of the translational factors eEF1A 1/2 correlate with cell growth but not apoptosis in hepatocellular carcinoma cell lines with different differentiation grade 201
Use of Rheology and portable Low-Field NMR for the monitoring of lung functions in cystic fibrosis patients 198
Use of low field nuclear magnetic resonance to monitor lung inflammation and the amount of pathological components in the sputum of cystic fibrosis patients 196
Rapid and cost-effective xenograft hepatocellular carcinoma model in Zebrafish for drug testing 195
Galactosylated polyaspartamide copolymers for siRNA targeted delivery to hepatocellular carcinoma cells 194
Evaluation of the contribution of the elongational factor 1 A isoforms in hepatocellular carcinoma celss growth 194
Comparison between recombinant baculo and adenoviral-vectors as transfer system in cardiovascular cells 193
Epigenetic and miRNAs dysregulation in prostate cancer: the role of nutraceuticals. 190
5-Azacytidine Downregulates the Proliferation and Migration of Hepatocellular Carcinoma Cells In Vitro and In Vivo by Targeting miR-139-5p/ROCK2 Pathway 190
Synthesis and Spontaneous Polymerization of Oligo(ethyleneglycol)-Conjugated Benzofulvene Macromonomers.A Polymer Brush Forming a Physical Hydrogel 187
Bortezomib effect of E2F and cyclin family members in human hepatocellular carcinoma cell lines 187
Drug delivery and mathematical modeling: an historical perspective 186
Cyclin E1, E2 and E2F1 targeted siRNAs down regulate the growth of coronary smooth muscle cell, thus showing their potential use in the prevention of in-stent restenosis 185
Hydrogels mesh size evaluation 185
Improving siRNA Bio-Distribution and Minimizing Side Effects 180
Effect of chest physiotherapy on cystic fibrosis sputum nanostructure: an experimental and theoretical approach 178
Aptamers as targeting delivery devices or anti-cancer drugs for fighting tumors 171
Potential applications of small interferring RNA in the cardiovascular field 169
Proliferation of human primary vascular smooth muscle cells depends on serum response factor. 166
E2F1 as a molecular drug target in ovarian cancer 165
Uso di small interfering RNA (SIRNA) per il trattamento di patologie caratterizzate da iperproliferazione cellulare 163
Synthesis and characterization of polyaspartamide copolymers obtained by ATRP for nucleic acid delivery 162
Nucleic Acids-based Aptamers and their applications 162
“Alpha-anomeric configuration of GT oligodeoxynucleotide leads to loss of specific aptameric and cytotoxic properties retained by the Beta-anomeric analog” 161
Propaedeutic study for the delivery of nucleic acid-based molecules from PLGA microparticles and stearic acid nanoparticles 161
In vitro and ex vivo delivery of tailored siRNA-nanoliposomes for E2F1 silencing as a potential therapy for colorectal cancer 160
Targeted delivery of siRNAs against hepatocellular carcinoma-related genes by a galactosylated polyaspartamide copolymer 160
Xenograft zebrafish models for the development of novel anti-hepatocellular carcinoma molecules 159
“The expression levels of the translational factors eEF1A1/2 correlate with the cell growth but not apoptosis in hepatocellular carcinoma cell lines with different differentiation grade” 157
The Role of the eEF1A Family in Human Cancers 157
SCHS SMART CREAM FOR A HEALTY SKIN 157
The targeting of the elongation factor 1A by a DNA aptamer impairs the viability of hepatocarcinoma cells 156
High eEF1A1 Protein Levels Mark Aggressive Prostate Cancers and the In Vitro Targeting of eEF1A1 Reveals the eEF1A1–Actin Complex as a New Potential Target for Therapy 156
“Can TIE-2 expressing monocytes represent a novel marker for Hepatocellular Carcinoma? 155
Development of a simple, biocompatible and cost-effective Inulin-Diethylenetriamine based siRNA delivery system 153
Mucus Structure, Viscoelastic Properties, and Composition in Chronic Respiratory Diseases 152
A pivotal study in human prostate cancer tissues and cell lines to measure the expression levels of eukaryotic Elongation Factor 1A proteins and the effect of a nucleic acid-based GT75 aptamer 151
"Reduction of mdr1 gene amplification in human multidrug resistant LoVo dX cellline is promoted by triple-helix forming oligonucleotides" 150
null 150
“Increase in therapeutic index of doxorubicin and vinblastine by aptameric oligonucleotide in human T-lymphoblastic drug sensitive and multidrug-resistance cells” 149
SiRNAs targeted against cyclin E1, cyclin E2 and E2F1 down regulate the growth of Hepatocellular Carcinoma showing their potential use in the prevention of this type of tumor 149
An Overview of siRNA Delivery Strategies for Urological Cancers 149
USO SINERGICO DELLA REOLOGIA E DELLA RISONANZA MAGNETICA NUCLEARE A BASSO CAMPO PER CARATTERIZZARE L’ESPETTORATO DI PAZIENTI CON FIBROSI CISTICA 148
null 148
In Vitro and In Vivo Evaluation of the Effects of Drug 2c and Derivatives on Ovarian Cancer Cells 147
Role of E2F1-cycline1-cycline2 circuit in hepatocellular carcinoma cell proliferation and therapeutic potential of its down-regulation by siRNAs 146
SIMPLE, BIOCOMPATIBLE AND COST-EFFECTIVE INULIN BASED siRNA DELIVERY SYSTEMS 146
Drug delivery and in vivo absorption 141
Targeting Non-Coding RNAs for the Development of Novel Hepatocellular Carcinoma Therapeutic Approaches 139
Hydrogel mesh size evaluation 138
“ Identification of different isoforms of eEF1A in the nuclear fraction of human T-lymphoblastic cancer cell lines specifically binding to aptameric cytotoxic GT oligonucleotides” 137
null 136
null 136
Effects of various promoter derived sequences on the cleavage kinetic of an hammerhead ribozyme directed against cyclin E1 mRNA. 135
Interaction of G-rich GT oligonucleotides with nuclear-associated eEF1A is correlated with their antiproliferative effect in haematopoietic human cancer cell lines. 132
Potential Application Of Proteasome Inhibitor Bortezomib For Treatment Of Hepatocellular Carcinoma 131
Totale 21.080
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.031
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.031
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021426 0 0 0 0 0 0 0 0 0 203 56 167
2021/20221.568 58 96 59 203 39 125 77 76 140 151 190 354
2022/20232.434 228 334 234 338 218 365 38 214 263 45 107 50
2023/20241.455 79 85 86 86 162 158 192 279 21 103 102 102
2024/20253.017 27 93 214 251 308 314 180 151 418 407 303 351
2025/20266.528 823 376 530 654 561 660 986 182 844 912 0 0
Totale 24.366